Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Reactogenicity of Fluarix in Korean Subjects
NCT00750360Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2003
- Primary completion
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of Fluarix in influenza, sponsored by GSK. Started Oct 2003; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00750360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00750360.